Management of dupilumab‐associated conjunctivitis in atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of dupilumab‐associated conjunctivitis in atopic dermatitis

Published:2019-03-15 Issue:5 Volume:17 Page:488-491
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Aszodi Nora¹,Thurau Stephan²,Seegräber Marlene¹³,Bruin‐Weller Marjolein⁴,Wollenberg Andreas¹³

Affiliation:

1. Department of Dermatology and AllergologyUniversity Medical Center Munich Germany

2. Department of Ophthalmology at MathildenstraßeUniversity Medical Center Munich Germany

3. Munich City Medical CenterThalkirchner Straße Munich Germany

4. Department of Dermatology and AllergologyUniversity Medical Center Utrecht The Netherlands

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.13809

Reference20 articles.

1. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

2. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

3. Dupilumab for treatment of atopic dermatitis

4. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

5. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis;Frontiers in Pharmacology;2024-08-01

2. Effets indésirables des biothérapies de l’asthme sévère;Revue des Maladies Respiratoires;2024-05

3. Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches;Frontiers in Immunology;2024-03-04

4. Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience;Advances in Dermatology and Allergology;2023

5. Dupilumab-induced ocular surface disease: a primer;BMJ Case Reports;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3